M2 Europharma articles from December 2001

M2 Europharma archives from December 2001

FDA approves NovoLog for insulin pumps.(Brief Article)
December 28, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD Novo Nordisk, a Danish healthcare group, has said that its NovoLog drug has been approved by the US Food and Drug Administration for use in insulin pumps. According to the group,...

IP2IPO acquires stake in Inhibox.(Brief Article)
December 28, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD IP2IPO, a subsidiary of the Beeson Gregory Group Plc, has acquired an interest in Inhibox Limited. Inhibox is a drug discovery company that uses computational methods to find leads...

Bioglan agrees to transfer Solaraze licensing deal.(Brief Article)
December 28, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD Bioglan Pharma has signed an agreement to transfer a licensing deal for marketing Solaraze skin-treatment to Quintiles Transnational Corp. The deal has been valued at GBP15m and is...

Solvay SA to acquire Ausimont.(Brief Article)
December 28, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD Solvay SA, a Belgian chemicals and drug company, has signed an agreement with Italy's Montedison SpA and Longside International SA to acquire the fluorinates manufacturer Ausimont. ...

Copy of Lundbeck's antidepressant drug approved in Europe.(from Tiefenbacher)(Brief Article)
December 28, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD A generic version of the Danish pharmaceutical group H. Lundbeck A/S' Cipramil antidepressant drug has been approved in nine European countries. The drug from Germany's Tiefenbacher...

AstraZeneca submits application to US health authorities for Casodex 150mg.(Brief Article)
December 28, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD The Anglo-Swedish pharmaceutical company AstraZeneca Plc has submitted a supplemental new drug application to the US Food and Drug Administration for its Casodex (bicalutamide 150mg) drug...

Pharmacia transfers sleep drug's US marketing rights to French drug group.(Sanofi-Synthelabo)(Brief Article)
December 28, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD The US-Swedish drug firm Pharmacia Corp has signed an agreement to transfer the US sales and marketing rights of Ambien, a prescription sleep drug, to the French pharmaceutical group...

AM-Pharma signs research partnership agreement with XTL Biopharm.(Brief Article)
December 20, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD Israeli-based XTL Biopharm has extended the human lactoferrin peptide research programme which it launched in November 2000 with Pharming Group NV to include AM-Pharma BV, a recently...

US health authorities approve Instrumentarium's incubator.(from Ohmeda Medical)(Brief Article)
December 20, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD Ohmeda Medical, a US-based division of the Finnish medical technology company Instrumentarium, has received clearance from the US Food and Drug Administration for its new Giraffe...

GlaxoSmithkline gets non-approval letter for new drug.(Augmentin XR Extended Release Tablets)(Brief Article)
December 20, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD The UK pharmaceuticals giant GlaxoSmithKline Plc has received a non-approval letter from the US Food and Drug Administration for its Augmentin XR Extended Release Tablets. Augmentin...

Pyrosequencing and Mayo Clinic partner to develop cancer detection tests.(Brief Article)
December 18, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD The Swedish biotechnology company Pyrosequencing AB has signed a collaborative research agreement with the US-based Mayo Foundation for Education and Research. Under the agreement...

Alexion Pharmaceuticals teams with Dutch hospital to study antibodies.(St. Radboud)(Brief Article)
December 17, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD The Dutch hospital St. Radboud has signed a four-year partnership agreement with US-based Alexion Pharmaceuticals Inc. Under the agreement the hospital and the pharmaceutical company...

US authorities approve GlaxoSmithKline's Paxil for treatment of PTSD.(Brief Article)
December 17, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD The UK pharmaceutical giant GlaxoSmithKline (GSK) has received approval from the US Food and Drug Administration to market its Paxil drug as a treatment for posttraumatic stress disorder...

Novartis gets US approval for eczema medication.(Elidel Cream)(Brief Article)
December 17, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD The Swiss-based pharmaceutical group Novartis AG has received marketing approval from the US Food and Drug Administration for its Elidel Cream eczema treatment. Novartis says that...

SkyePharma and Astralis team to develop new psoriasis treatment.(second generation version of Psoraxine)(Brief Article)
December 17, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD The British biotechnology company SkyePharma Plc has joined forces with its US counterpart Astralis Ltd to develop Astralis' new Psoraxine vaccine therapy for the treatment of all forms...

Aventis partners with ViroPharma for product promotion in US markets.(Brief Article)
December 17, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD US-based ViroPharma Inc and Aventis Pharmaceuticals, a US-based unit of the French-German drugs/chemical group Aventis, have signed a new collaboration agreement. Under an agreement...

Biomedix to halt development of osteoarthritis drug.(Brief Article)
December 14, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD The UK pharmaceutical firm KS Biomedix Holdings Plc has decided to stop the development of its KSB301osteoarthritis drug following inconclusive clinical data. The company says that...

German research centre selects Pyrosequencing's DNA sequencing system.(Brief Article)
December 14, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD Swedish-based Pyrosequencing AB has sold a customised version of its new DNA sequencing system for applied genetic analysis to the Max Delbruck Center for Molecular Medicine in Berlin,...

Novo Nordisk expands in Latin America.(acquires Biobras SA)(Brief Article)
December 14, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD The Danish pharmaceutical company Novo Nordisk A/S has signed an agreement to acquire a controlling stake in Biobras SA, a Brazilian firm that manufactures diabetes care products. In...

Osmotech launches clinical study of electronic sensor for bacterial vaginosis.(Brief Article)
December 14, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD Osmetech Plc, a UK-based company that develops electronic odour sensors for the medical diagnostics industry, has begun clinical trials of its new bacterial vaginosis (BV) sensor device....

A-VIRAL completes NOK15m offering.(Brief Article)
December 14, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD The Norwegian biotechnology company A-VIRAL AS reports that it has successfully closed a directed offering of NOK15m. A-VIRAL, which has research programmes in the areas of virology...

Japanese authorities approve Biora's periodontal disease treatment.(Brief Article)
December 14, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD The Swedish pharmaceutical company Biora AB has received permission from the Japanese regulatory authorities to market its EmdogainGel dental product in Japan. EmdogainGel is a drug...

Inoxell and AstraZeneca reach first milestone in research project.(CellScreen drug target identification technology)(Brief Article)
December 14, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD The Danish drug discovery company Inoxell A/S and the Anglo-Swedish drug group AstraZeneca Plc report that they have achieved the first milestone in their partnership to evaluate Inoxell's...

Genmab to launch phase III study of new drug.(Brief Article)
December 13, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD The Danish biotechnology company Genmab A/S has received permission from the US Food and Drug Administration to start a phase III clinical study of its HuMax-CD4 drug. The study will...

Pharmacore gets SEK45m from investors.(Brief Article)
December 13, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD The Swedish-based research company Pharmacore AB has received an investment worth SEK45m from the venture capital firms A+ Science Invest AB, InnovationsKapital and Swedestart. ...

Q-Med opens US head office.(Brief Article)
December 13, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD Q-Med AB, a Swedish-based company that develops and markets medical implants, has opened a US head office in Washington DC. Q-Med is also building a sales organisation in preparation...

New drug from AstraZeneca shows promise as breast cancer treatment.(Arimidex)(Brief Article)
December 11, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD The Anglo-Swedish drug group AstraZeneca Plc reports that the first results from a breast cancer treatment trial show that its Arimidex drug is more effective than the commonly used drug,...

Wellcome Trust to reduce investment in GlaxoSmithKline.(Brief Article)
December 10, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD The Wellcome Trust, a UK-based charity that funds medical research, has decided to reduce its direct investment in the pharmaceuticals giant GlaxoSmithKline Plc (GSK) to rebalance its...

IBM and Lion Bioscience team to help drug developers harness genome data.(International Business Machines Corp.)(Brief Article)
December 10, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD The US-based information technology giant International Business Machines Corp (IBM) and the German biotechnology firm Lion Bioscience AG have formed an alliance to speed up the discovery...

Acambis and Baxter win US smallpox vaccine contract.(Brief Article)
December 10, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD A consortium comprising the British biotechnology firm Acambis Plc and Baxter AG Oesterreich, the Austrian subsidiary of the US-based biotechnology concern Baxter International, has won a...

Lundbeck's most important drug faces competition from generic versions.(Cipramil)(Brief Article)
December 10, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD The US drugmaker Alpharma Inc has unveiled plans to launch a generic version of the Danish company H. Lundbeck A/S' flagship product, the Cipramil antidepressant, in several European...

Reactionlab becomes IGEN International's distributor in Nordic countries.(Brief Article)
December 10, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD The US-based biotechnology company IGEN International Inc has signed a distribution agreement with Reactionlab. Under the non-exclusive agreement Reactionlab will sell IGEN's...

Shire gets US patent for Adderall XR drug.(Shire Pharmaceuticals Group Plc)(Brief Article)
December 10, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD Britain's Shire Pharmaceuticals Group Plc has received US patent protection for Adderall XR, its once-daily treatment for hyperactive children. The US Patent and Trademark Office...

Epix's and Schering's contrast agent shows promise as arthritis drug.(EPIX Medical Inc., Schering AG)(Brief Article)
December 10, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD The US pharmaceutical company Epix Medical Inc reports that MS-325, an injectable magnetic resonance imaging contrast agent it is developing together with the German drugmaker Schering AG,...

US authorities approve Shire's screening tool.(CADx Medical Systems subsidiary)(Brief Article)
December 10, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD The CADx Medical Systems subsidiary of Britain's Shire Pharmaceutical Group Plc has received approval from the US Food and Drug Administration (FDA) for its Second Look computer-aided...

Sweden approves Lundbeck's new depression and panic disorder drug.(H. Lundbeck A/S)(Brief Article)
December 10, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD The Danish pharmaceutical company H. Lundbeck A/S has received approval from Sweden's Medical Products Agency to market its Cipralex drug as a treatment for depression and panic...

Clinical trial shows Bayer's new erectile dysfunction treatment works.(Vardenafil )(Brief Article)
December 10, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD The German pharmaceutical company Bayer AG reports that its Vardenafil drug for erectile dysfunction has achieved positive results in a large-scale clinical trial. The study...

GlaxoSmithKline and Roche team to develop osteoporosis treatment.(ibandronate)(Brief Article)
December 10, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD The UK pharmaceuticals giant GlaxoSmithKline Plc (GSK) and the Swiss group Roche Holding AG have signed an agreement to jointly develop and market Roche's new drug for the treatment of...

Gambro opens new membrane dialyser plant.(Brief Article)
December 5, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD The Swedish medical technology and healthcare company Gambro AB has opened a new production plant for synthetic membrane dialysers in Hechingen, Germany. The Hechingen plant will make...

FIT Biotech to launch human study of HIV/AIDS vaccine.(Brief Article)
December 5, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD The Finnish biotechnology company FIT Biotech Plc has received approval from Finland's National Agency for Medicines to begin a clinical trial of a new HIV/AIDS vaccine. The...

Baxter to pay compensation for deaths of ten kidney-dialysis patients.(Baxter International Inc. awards families in Spain)(Brief Article)
December 5, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD US-based Baxter International Inc has agreed to pay about USD294,000 to each of the families of ten Spanish kidney-dialysis patients whose recent deaths apparently were caused by the...

Novo Nordisk teams with US company to develop new diabetes treatments.(TransTech Pharma Inc.)(Brief Article)
December 4, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD The Danish pharmaceutical company Novo Nordisk A/S has signed a three-year research collaboration agreement with the US drug discovery firm TransTech Pharma Inc. The two companies...

AstraZeneca unveils plan for several product launches in 2002.(Crestor, Iressa, Faslodex and Exanta)(Brief Article)
December 4, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD The Anglo-Swedish drug group AstraZeneca Plc has reported that its pipeline of new medicines is on track, with a series of product launches planned for next year. The group is trying...

Italian researcher to begin trials of new AIDS vaccine.(Barbara Ensoli)(Brief Article)
December 4, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD The Italian health minister Girolamo Sirchia has revealed that tests of a prototype of an AIDS vaccine will start soon in Italy, possibly before Christmas. The vaccine is being...

Roche and deCODE find gene linked to rheumatoid arthritis.(Brief Article)
December 3, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD The Icelandic biotechnology company deCODE genetics and Roche Diagnostics, part of the Swiss healthcare group Roche Holding AG, report that they have mapped a gene linked to the joint...

US authorities approve generic version of AstraZeneca's Prilosec.(by Andrx Corp.)(Brief Article)
December 3, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD The US Food and Drug Administration (FDA) has approved the application of Florida-based Andrx Corp to market a generic version of AstraZeneca Plc's Prilosec ulcer and heartburn...

atugen and Byk Gulden sign technology evaluation agreement.(Brief Article)
December 3, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD The Berlin-based biotechnology company atugen AG has signed a partnership agreement with Byk Gulden, the pharmaceuticals division of Germany's Altana AG. Under the agreement the two...

British scientists to launch depression study.(University of Birmingham study funded by GlaxoSmithKline)(Brief Article)
December 3, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD A team of scientists at the University of Birmingham is due to start a study of siblings who have both experienced two or more episodes of depression in their lives. The aim of the...

Bayer forms research pact with Italy's Axxam.(Brief Article)
December 3, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD The German pharmaceutical giant Bayer AG has formed a drug discovery partnership with the Italian biotechnology company Axxam SRL. As part of the agreement Bayer will integrate its...

Bayer and GlaxoSmithKline form marketing partnership.(for drug Vardenafil)(Brief Article)
December 3, 2001... M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD Germany's Bayer AG and the UK pharmaceutical company GlaxoSmithKline Plc (GSK) have signed a co-promotion agreement for Vardenafil, a new drug developed by Bayer for the treatment of...